United States-based medical devices and health care company Abbott (NYSE: ABT) announced on Friday that its board of directors declared a quarterly common dividend of USD0.59 per share.
This represents the 405th consecutive quarterly dividend since 1924. Payment is scheduled for 15 May 2025, to shareholders of record as of 15 April 2025.
Abbott has raised its dividend for 53 consecutive years. Inclusion in the S&P 500 Dividend Aristocrats Index reflects its commitment to annual dividend increases for over 25 years.
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
Qlife secures UK approval to initiate clinical trial for Egoo Phe System
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Avance Biosciences registers with CLIA program
Abbott announces quarterly common dividend
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan